Inappropriate microvascular constriction produced transient ST-segment elevation in patients with syndrome X  by Murakami, Hironori et al.
Inappropriate Microvascular Constriction Produced Transient
ST-Segment Elevation in Patients With Syndrome X
HIRONORI MURAKAMI, MD, PHD, KAZUYUKI URABE, MD, PHD,
MITSUHIRO NISHIMURA, MD, PHD
Sapporo, Japan
Objectives. The aim of this project was to study the responsible
site(s) and underlying cardiac disease(s) of patients with tran-
sient ST-segment elevation and normal coronary angiograms.
Background. Transient ST-segment elevation has been demon-
strated in patients with variant angina or unstable angina. In
those patients, epicardial coronary arteries, not microvessels, are
always the responsible site for the transient ST-segment elevation.
Methods. This study consisted of three cases with a transient
ST-segment elevation and normal coronary angiograms. Tread-
mill testings were performed before coronary angiography in all
cases. Coronary angiography was undertaken during the control
state and during ST-segment elevation and, when possible, a
Doppler guide wire was positioned in the left anterior descending
artery (LAD). Coronary responses to vasodilators were observed.
Finally, cardiac biopsy was performed and pathologic observation
was conducted.
Results. All three cases had significant ST-segment depression
during treadmill testing in II, III, aVF and V4–6 leads; however, no
angiographic coronary stenosis was demonstrated and vasospasm
was not provoked. A transient ST-segment elevation associated
with chest pain was observed in V1–5 leads, but normal coronary
angiograms during ST-segment elevation were observed in every
case. Coronary blood flow (CBF) velocity profile remained normal
during ST-segment elevation. In one case, vasodilator responses
to the LAD during ST-segment elevation were also measured. A
0.5 mg intracoronary injection of nitroglycerin increased CBF
velocity (220%), but ST-segment elevation was not normalized and
chest pain persisted. A 10 mg intracoronary injection of papaver-
ine (PVN) further increased CBF velocity up to 340%, and this
normalized ST-segment elevation and relieved chest pain quickly.
Either endothelium-dependent coronary flow reserve (CFR) mea-
sured with a 100 mg intracoronary infusion of acetylcholine, or
flow-dependent CFR by a 10 mg intracoronary injection of PVN
was reduced in one of two cases measured. Pathologic findings
supported syndrome X as the underlying cardiac disease in all
cases.
Conclusions. These findings suggested a new clinical implica-
tion involving transient ST-segment elevation mimicking variant
angina and normal coronary angiograms in patients with syn-
drome X. The major responsible site for this phenomenon was
suggested to be coronary arterioles of less than 200 mm in
diameter.
(J Am Coll Cardiol 1998;32:1287–94)
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Angiographic coronary stenosis used to be demonstrated dur-
ing every attack of transient ST-segment elevation. The re-
sponsible mechanism was thought to be epicardial coronary
vasospasm (1–3) or unstable angina (3). On the other hand,
syndrome X is diagnosed by chest pain, exercise-induced
ST-segment depression and the absence of either significant
epicardial coronary stenosis or vasospasm (4–7). Some pa-
tients with syndrome X have some pathologic changes around
microvessels themselves and sometimes the myocardium.
However, there has been no report so far of a spontaneous
attack manifesting ST-segment elevation mimicking variant
angina in patients with syndrome X.
We observed transient ST-segment elevation mimicking
variant angina and normal coronary angiograms in three cases
with chest pain. Thus, the aim of this study was 1) to study the
responsible site(s) for ST-segment elevation, 2) to investigate
the underlying cardiac disease(s) and 3) to examine vasodilator
responses to acetylcholine (Ach) and papaverine (PVN).
Methods
We selected three consecutive cases (2 women and 1 man)
from October 1, 1996 to December 22, 1997, who had a
transient ST-segment elevation during cardiac catheterization
and normal coronary angiograms. Before the coronary angiog-
raphy, Holter 24-h monitoring (Marquette Electronics, Inc.,
Wisconsin) treadmill testing with modified Bruce protocol or
modified Balke protocol using a Case 15 (Marquette Electron-
ics, Inc., Wisconsin) and echocardiographic examination with a
2.5 or 3.75 MHz transducer (Toshiba SSH-160A, Kawasaki,
Japan) were performed. Control coronary angiography was
performed initially and provocation of coronary vasospasm was
done by an intracoronary infusion of acetylcholine (Ach)
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(50 mg to the right coronary artery and 100 mg to the left
coronary artery) if normal coronary angiograms had been
obtained. Five French of Judkins type catheters for both
coronary arteries were used to conduct the angiography using
a biplane cineangiography (Philips Polydiagnost, The Nether-
lands). During a spontaneous attack of ST-segment elevation,
coronary angiography of the left coronary artery was done as
quickly as possible because the elevated ST-segments in all
cases had been observed in V1–5 leads. Then, coronary blood
flow (CBF) velocity was measured with a 0.0140 of Doppler
guide wire (FloWire, Cardiometrics, Inc., California) at seg-
ment 7 of the left anterior descending artery (LAD). Coronary
responses to an intracoronary injection of vasodilators (0.5 mg
of nitroglycerin [NTG] and 10 mg of papaverine [PVN]) were
observed during ST-segment elevation, if possible. After the
transient ST-segment elevation had disappeared completely,
control CBF velocity at segment 7 of the LAD was measured.
Then, Ach (100 mg) was again infused into the left coronary
artery to measure endothelium-dependent coronary flow re-
serve (CFR). After this procedure, PVN (10 mg) was injected
into the left coronary artery to determine flow-dependent
CFR. Finally, cardiac biopsy from the right ventricle was
undertaken to determine pathologically the underlying cardiac
disease.
Results
Patients’ characteristics (Table 1). Three cases with nor-
mal sinus rhythm showed a spontaneous attack of ST-segment
elevation. All of the cases had a history of anginalike chest pain
at rest, but did not have a clear history of chest pain during
exercise. In all three cases, chest pain used to last for a long
time, over 30 min, and a sublingual NTG administration
sometimes failed to relieve chest pain, which suggested a
psychologic influence upon the chest pains. All the cases had
periodic recurrences of chest pain in a 1-year period without
any provocation factors. Case 2 had hypertension and Hashi-
moto disease with normal thyroid function, but the other two
cases had no other diseases. No one had either a smoking habit
or relatives with similar symptoms.
Before admission, cases 1 and 2 had been administered
nitrate, calcium antagonist, beta-adrenergic blocking agents
and antidepressant, but case 3 had had no medication.
Treadmill testing, Holter 24-h monitoring and echocardi-
ography. Holter 24-h monitoring demonstrated some epi-
sodes of significant ST-segment depression in all cases during
daily activities. However, their chest symptoms sometimes did
not coincide with episodes of ST-segment depression, and
episodes of significant ST-segment depression without any
symptoms similar to silent ischemia were seen. No episode of
ST-segment elevation was observed before coronary angiogra-
phy.
Treadmill testing was performed with modified Bruce pro-
tocol in cases 2 and 3, and with modified Balke protocol in case
1. Treadmill testing was ended by satisfying the criteria of
diagnostic ST-segment depression (Table 1). The magnitude of
maximum ST-segment depression was 2.0 mm in V5 and V6
leads in case 1, 2.0 mm in V5 lead in case 2 and 1.5 mm in III
lead in case 3. Anginalike chest pain was not provoked in any
of the cases by treadmill testing, even during peak exercise.
Echocardiographic examination demonstrated either no
abnormal wall motion or normal-looking echocardiograms at
rest. Thus, neither underlying myocardial disease, including
cardiac hypertrophy, nor valvular disease, except for angina or
anginalike disorders, was found in any of the cases. Systolic and
diastolic function were not impaired either. Ejection fraction
of the left ventricle was 75% in case 1, 60% in case 2 and 58%
in case 3.
Transient ST-segment elevation (Figs. 1, 2 and 3). In all
cases, a transient ST-segment elevation was demonstrated
during cardiac catheterization (Figs. 1B, 2B and 3C). In case 1,
the ST-segment elevated from V1 to V5 leads, and a slight
reciprocal ST-segment depression was found in II, III and aVF
leads (Fig. 1B). Coronary angiography of the left coronary
artery was performed, and CBF velocity in the LAD was
measured during the ST-segment elevation. In this case,
coronary responses to intracoronary NTG and PVN were
measured. Severe chest pain was complained of during ST-
segment elevation in this case.
Abbreviations and Acronyms
Ach 5 Acetylcholine
APV 5 Average peak velocity
CBF 5 Coronary blood flow
CFR 5 Coronary flow reserve
LAD 5 Left anterior descending artery
NTG 5 Nitroglycerin
PVN 5 Papaverine
Table 1. Summary of Patients’ Characteristics
Case 1 Case 2 Case 3
Age (yr) 75 73 58
Gender Female Female Male
Chest pain
At rest (1) (1) (1)
During exercise (2) (2) (2)
Risk factors
Smoking (2) (2) (2)
Hypertension (2) (1) (2)
Hyperlipidemia (2) (2) (2)
Diabetes mellitus (2) (2) (2)
Treadmill
Peak HR (/min) 121 133 140
% of maximum HR* (%) 83 91 87






*HR 5 heart rate.
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In case 2, the ST-segment elevation was recognized from V1
to V6 leads (Fig. 2B). Increased magnitude of positive T wave
was recognized in II, III and aVF leads. Coronary angiography
of the left coronary artery was performed and CBF velocity in
the LAD was measured during the ST-segment elevation, but
coronary responses to vasodilators during the ST-segment
elevation could not be investigated because of spontaneous
regression of the ST-segment elevation. In this case as in case
1, the patient also complained of severe chest pain during the
ST-segment elevation.
In case 3, the ST-segment elevation was found from V1 to
V6 leads (Fig. 3C). In addition, an episode of ST-segment
depression was also found from V1 to V6 leads and in II, III
and aVF leads (Fig. 3B). Because of spontaneous regression of
this attack within a few minutes, only coronary angiography
could be performed to confirm whether a newly developed
coronary stenosis due to coronary spasm had occurred during
the ST-segment elevation. There was no complaint of chest
pain during ST-segment change in this case.
In all the cases, normal angiograms of the left coronary
artery were demonstrated during the ST-segment elevation
(Figs. 2D, 3E and 4B). Coronary blood flow velocity profiles
during the ST-segment elevation also remained normal in
cases 1 and 2.
Changes in each state of average peak velocity (APV) were
also demonstrated, as shown in Table 2. Average peak velocity
during the ST-segment elevation was 10 cm/s in case 1 (Fig.
5A). An intracoronary NTG infusion (0.5 mg) decreased the
severity of chest pain and the magnitude of the ST-segment
elevation (Fig. 1C), but did not cure it completely. Average
peak velocity was increased to 22 cm/s by NTG infusion (Fig.
5B). After NTG infusion, a 10-mg infusion of intracoronary
PVN followed. Papaverine further increased the APV up to
34 cm/s (Fig. 5C) and normalized ST-segment very quickly
(Fig. 1D). Chest pain also disappeared quickly after PVN
infusion. No significant epicardial coronary stenosis was dem-
onstrated after either NTG infusion (Fig. 4C) or PVN infusion
(Fig. 4D), as was the case with the control (Fig. 4A), or during
the ST-segment elevation (Fig. 4B).
The co-existence of coronary vasospasm and measurement
of CFR (Table 2). A 100-mg infusion of intracoronary Ach to
the left coronary artery did not provoke coronary vasospasm in
any of the cases, as was also demonstrated for a 50-mg
intracoronary infusion of Ach to the right coronary artery. In
cases 2 and 3, coronary responses to vasodilators were mea-
sured during control state. An intracoronary infusion of Ach
(100 mg) increased APV in cases 2 and 3. An intracoronary
PVN infusion (10 mg) also increased APV of the LAD in cases
2 and 3. Thus, endothelium-dependent CFR was calculated as
1.2 in case 2 and 2.8 in case 3, while flow-dependent CFR was
calculated as 1.5 in case 2 and 2.3 in case 3.
Figure 1. Serial electrocardiographic changes in case 1. (A) Control
electrocardiography at rest: (B) the transient ST-segment elevation;
(C) after a 0.5-mg infusion of intracoronary NTG; (D) after a 10-mg
infusion of intracoronary PVN.
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Cardiac biopsy from the right ventricle. In case 1, perivas-
cular fibrosis and fibromuscular dysplasia of the media were
clearly demonstrated (Fig. 6A), as were focal interstitial fibro-
sis and perinuclear halo of the myocardium (Fig. 6B). Perivas-
cular fibrosis was found in the other cases, while fibromuscular
dysplasia of the media was found only in case 2. Mild focal
interstitial fibrosis was also observed in case 2, while myocar-
dial hypertrophy was documented only in case 3.
Discussion
ST-segment elevation and syndrome X. Transient ST-
segment elevation has been demonstrated only in patients with
variant angina (1–3) or unstable angina (3). In those patients,
epicardial coronary arteries, not microvessels, are always the
responsible site for the transient ST-segment elevation. On the
other hand, syndrome X is a particular cardiac disorder known
as microvascular angina existing in combination with neither
atherosclerotic epicardial coronary stenosis nor coronary va-
sospasm (4–7). This is usually diagnosed by findings of angi-
nalike chest pain, exercise-induced significant ST-segment
depression and normal coronary angiograms (4–7).
We reported here three cases with spontaneous transient
ST-segment elevation. All of the cases satisfied the above
criteria as syndrome X. In addition, they also had pathologic
findings in the perivascular region or the myocardium itself,
which supported the diagnosis of syndrome X.
Previously, ergonovine- or Ach-induced, but not spontane-
ous, ST-segment elevation with normal coronary angiograms
was reported (8,9), and this finding may be consistent with
provoked microvascular constriction. Very recently, Yamagishi
et al. (10) and Mohri et al. (11) reported a single case with a
transient spontaneous ST-segment elevation with normal cor-
onary angiograms. However, neither of the above cases could
provide concrete evidence of syndrome X. The former showed
no exercise-induced ST-segment changes, and the latter made
no report of these changes. Thus, to the best of our knowledge,
there has been no clear report demonstrating spontaneous
transient ST-segment elevation mimicking variant angina or
unstable angina in patients with syndrome X. Furthermore,
this would also be the first report providing evidence that small
vessels are one of the important responsible sites for angina
with ST-segment elevation.
Different vasodilator responses to NTG or PVN and ST-
segment elevation in case 1. In case 1, NTG did not normalize
the ST-segment elevation or relieve chest pain (Fig. 1C), while
PVN did both, relieving chest pain completely (Fig. 1D). It is
Figure 2. Serial electrocardiographic changes and coronary angio-
grams in case 2. (A) Control electrocardiography at rest; (B) the
transient ST-segment elevation; (C) a control coronary angiogram; (D)
a coronary angiogram during the ST-segment elevation.
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known that NTG dilates only vessels greater than 200 mm in
diameter (12,13), while PVN dilates both those of greater and
lesser diameter (7,14,15). Therefore, these findings suggested
that the major responsible site for this ST-segment elevation
attack may be vessels of less than 200 mm in diameter, although
the vessels greater than 200 mm may play a partial role in this
phenomenon.
Figure 4. Coronary angiograms of the left coronary
artery in case 1. (A) A control coronary angiogram; (B)
a coronary angiogram during the ST-segment elevation;
(C) a coronary angiogram after a 0.5-mg intracoronary
NTG infusion; (D) a coronary angiogram after a 10-mg
intracoronary PVN infusion.
Figure 3. Serial electrocardiography changes and coronary angio-
grams in case 3. (A) Control electrocardiography at rest. This electro-
cardiographic was obtained at the end of cardiac catheterization
because ST-segment changes (B and C) were observed just after
cardiac catheterization was begun. (B) A transient ST-segment depres-
sion; (C) the transient ST-segment elevation; (D) a control coronary
angiogram; (E) a coronary angiogram during the ST-segment eleva-
tion.
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CBF velocity profile and the possible cause of transient
ST-segment elevation. In cases 1 and 2, CBF velocity profile
remained normal during the ST-segment elevation. In case 2,
APV during the ST-segment elevation was similar to that
during control. These findings may lead to the hypothesis that
a heterogeneous distribution of microcirculatory vasoconstric-
tion may occur during ST-segment elevation, but areas with
this phenomenon may be significantly large.
The cause of inappropriate vasoconstriction was not clearly
understood. Different responses to vasodilators (NTG and
PVN) in case 1 indicated that the responsible site was arte-
rioles of less than 200 mm in diameter, as described before. It
is surprising that inappropriate vasoconstriction in our cases
Figure 5. Representative CBF profile of the
LAD with a Doppler guide wire in case 1. (A)
During the ST-segment elevation; (B) after an
intracoronary infusion of 0.5 mg of NTG; (C)
after an intracoronary infusion of 10 mg of
PVN.
Table 2. Changes in Average Peak Velocity, Endothelium-
Dependent and Flow-Dependent Coronary Flow Reserve of the Left
Anterior Descending Artery at Each State
Case 1 Case 2 Case 3
Control (cm/s) (2) 28 30
During ST-segment elevation (cm/s) 10 29 (2)
Acetylcholine (cm/s) (2) 33 85
Papaverine (cm/s) (2) 42 68
EDCFR (2) 1.2 2.8
FDCFR (2) 1.5 2.3
Average peak velocity was measured with a Doppler guide wire. Acetylcho-
line 5 a 100 mg intracoronary infusion of acetylcholine. Papaverine 5 a 10 mg
intracoronary infusion of papaverine. EDCFR 5 endothelium-dependent coro-
nary flow reserve; FDCFR 5 flow-dependent coronary flow reserve.
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exceeded autoregulatory function spontaneously and led to
expanded cardiac ischemia. It is known that interaction of
several vasoconstrictive substances (6,16–20) and neural stim-
uli (19) and/or reduced function of vasodilators (21–27) results
in vasoconstriction of microvessels. The net effects of some of
these factors may exceed autoregulatory function, resulting in
elevated ST-segment. Marcus et al. (15) reported that almost
50% of coronary vascular resistance was made by the vessels of
less than 100 mm in diameter. During the ST-segment eleva-
tion in our cases, therefore, it was not surprising that vessels of
less than 100 mm in diameter constituted the responsible site
for this phenomenon. Response to PVN during the ST-
segment elevation in case 1 may be consistent with this view.
The total area with severely reduced blood flow caused by
inappropriate vasoconstriction may occupy a significant area
producing severe ischemia, but vasoconstriction may occur
heterogeneously, as we described, because the normal coro-
nary blood flow profile remained at the proximal site.
Endothelial dysfunction and microvascular dysfunction.
Previous reports (28–31) described reduced endothelium-
dependent vasodilation assessed by intracoronary infusion of
Ach in patients with syndrome X. In our cases, impaired
endothelium-dependent vasodilation was demonstrated in case
2 but not in case 3. Since we had only a small number of cases,
we could not conclude whether impaired endothelium-
dependent vasodilation co-existed in patients with syndrome X
combined with transient ST-segment elevation.
Egashira et al. (30) reported that PVN induced lactate
production and chest pain, with electrocardiographic change
suggesting cardiac ischemia. They presumed that there may be
microvascular dysfunction other than endothelial dysfunction
in patients with syndrome X because PVN dilated coronary-
resistant vessels independently of endothelial function. They
also presumed that PVN produced cardiac ischemia due to the
coronary steal phenomenon, because different spatial vasodi-
latory responses to PVN between diseased vessels and normal
vessels produced different coronary resistance. From this view,
Maseri et al. (6) and others (31,32) have proposed the mech-
anism responsible for ischemic change of syndrome X as being
inappropriate vasoconstriction at the “prearteriolar” level,
concomitant with the steal phenomenon due to compensatory
“arteriolar” vasodilation. However, our findings, especially the
different responses to NTG and PVN in case 1, could not be
explained by their hypothesis. We presumed, as described
before, that multiple inappropriate vasoconstriction of mi-
crovessels of less than 200 mm in diameter in certain areas, not
associated with compensatory arteriole dilation, may have
been the possible cause for the transient ST-segment elevation.
Maseri et al. (6) suggested adenosine as a possible mediator
of anginal pain. Emdin et al. (5) also reported that aminophyl-
lin, an adenosine receptor blocker, improved exercise capacity
and exercise-induced chest pain. These data supported the
transmural maldistribution hypothesis as a genesis of ischemic
change in patients with syndrome X. In this context, our data
may also be inconsistent with their hypothesis.
Clinical outcome and implication. Chest pain in cases 1
and 2 could not be controlled completely by several drugs such
as nitrate, nicorandil, Ca-antagonist, theophyllin, beta-blocker
and antidepressant. The patients had mainly complained of
chest pains at rest. Surprisingly, their chest pain disappeared
after the administration of the same drugs for relief of chest
pain at a period several months later. Maseri et al. (6)
described prolonged chest pain and Kaski et al. (4) and
Cannon et al. (31) reported the occurrence of chest pain at rest
or during mild exercise. As with their patients, ours sometimes
had prolonged chest pain at rest which was not relieved by
medical treatment. Thus, clinical manifestations may vary,
ranging from chest pain without ST-segment change to chest
pain with ST-segment elevation in the same patient due to the
extent of the area with inappropriate circulation.
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